Investigations into the characteristics of BA.2, including immune escape properties and virulence, should be prioritised independently (and comparatively) to BA.1, said the World Health Organisation (WHO). The BA.2 Omicron sub-lineage differs from BA.1 in some of the mutations, including in the spike protein, the WHO wrote on its website.

from World News Headlines, Latest International News, World Breaking News - Times of India https://bit.ly/3g8TUeg
via IFTTT


This free site is ad-supported. Learn more